COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition.
For more than 10 years the National Cancer Institute (NCI) has tested compounds for their ability to inhibit the growth of human tumor cell lines in culture (NCI screen). Work of Ken Paull [J. Natl. Cancer Inst. 81 (1989) 1088] demonstrated that compounds with similar mechanism of cell growth inhibition show similar patterns of activity in the NCI screen. This observation was developed into an algorithm called COMPARE and has been successfully used to predict mechanisms for a wide variety of compounds. More recently, this method has been extended to associate patterns of cell growth inhibition by compounds with measurements of molecular entities (such as gene expression) in the cell lines in the NCI screen. The COMPARE method and associated data are freely available on the Developmental Therapeutics Program (DTP) web site (http://dtp.nci.nih.gov/). Examples of the use of COMPARE on these web pages will be explained and demonstrated. Published by Elsevier Science Inc.
Zaharevitz
Daniel W
DW
Information Technology Branch, Developmental Therapeutics Program, National Cancer Institute, Bethesda, MD 20892, USA. zaharevitz@dtpax2.ncifcrf.gov
Holbeck
Susan L
SL
Bowerman
Christopher
C
Svetlik
Penny A
PA
D000465:Algorithms; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D003627:Data Interpretation, Statistical; D016208:Databases, Factual; D004353:Drug Evaluation, Preclinical; D006131:Growth Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D020407:Internet; D016014:Linear Models; D012984:Software; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D006131:Growth Inhibitors